In cancer therapy, novel chemotherapeutic agents are being developed continually, 1) however, cancer-induced lethality is still high in many countries because of recalcitrant tumors and the appearance of resistant tumors. Furthermore, adverse reactions by antitumor drugs not only inhibit the therapeutic index but also require the use of combined agents to decrease these adverse reactions and the quality of life (QOL) of patients can worsen. While the development of novel antitumor drugs is a long and costly process, increasing the effectiveness of current therapies is also very important and should be addressed in clinical trials. As an example combined medicines, such as p-glycoprotein inhibitor in resistant tumors, have been used to increase the effectiveness of current antitumor agents. [2][3][4] From the viewpoint of biochemical modulation, combined medicines such as Tegaful have been applied in clinical therapy. However, it has been reported that some combined therapies increase the adverse effects of antitumor drugs as the antitumor effect increases, 5) and effective enhancement of the therapeutic index is not achieved. Furthermore, the QOL of patients can be affected negatively by many medicines. It is hoped to increase antitumor agent activity by combining antitumor therapies with foods that do not show adverse reactions or decrease QOL.From such a viewpoint, it was reported previously that theanine, an amino acid peculiar to green tea, has properties to increase the efficacy of doxorubicin (DOX) as an antitumor drug. 6) This action is due to the glutamate transporter expressed in the tumor cell membrane and is dependent on the influx inhibition of glutamate by theanine inhibition of this transporter and the resulting decrease in glutathione (GSH) synthesis.
7)Theanine did not increase DOX-induced adverse reactions in normal tissue, whereas reduced its adverse effects, and was therefore effective in enhancing the antitumor effect while decreasing the adverse effects of antitumor drugs. It is expected that there are other compounds with similar effectiveness, such as an amino acids or peptides, in other foods.Taurine (2-amino ethanesulfonic acid) is a major amino acid in fish and is found in all mammalian tissues. In clinical therapy, taurine is used to protect the liver and improve function with congestive cardiac failure. This study investigated the effect of taurine on the tumor cell permeability of DOX in vitro, studied its action on the antitumor effect of DOX in vivo, and elucidated the novel effect of taurine to increase DOX-induced antitumor activity.
MATERIALS AND METHODSChemicals Taurine, b-alanine was purchased from Wako Pure Chemical Industries, Ltd. (Tokyo, Japan). DOX 10 mg/vial (Adriacin), was purchased from Kyowa Fermentation, Inc. (Tokyo, Japan). RPMI 1640 medium was purchased from Nissui Pharmaceutical Co., Ltd. (Tokyo, Japan). [ 3 H]-Taurine (9.5 MBq/mmol) was purchased from Amersham (Tokyo, Japan). Scintillation cocktail Scientisol Ex-H ® , balanine, and g-amino butyric acid (GABA) wer...